2nd Quarter - Termination
WINNING STRATEGIES WASHINGTON for MEDA PHARMACEUTICALS
Client
Income
$20,000
Expenses
—
Terminated
Apr 30, 2011
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA Risk Evaluation and Mitigation Strategies
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| MICHAEL A MEROLA | — |
Pharmacy PHA
FDA Risk Evaluation and Mitigation Strategies
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| MICHAEL A MEROLA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.